LAMA2 and congenital muscular dystrophy: Together, these results suggest the NODScid dyW is a viable immunocompromised model for LAMA2-CMD, that while presenting reduced levels of basal muscle regeneration, disease progression is comparable to the established dyW model and similar to LAMA2-CMD patients.